Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

85,236 Press Releases · RSS · Email

Published on December 11, 2018 - 13:30 GMT

Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors

DUBLIN, Ireland, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, today announced that Kevin Kotler, the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:30 GMT

Cellectar Granted Japanese Patent for CLR 131

FLORHAM PARK, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, announces that the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:30 GMT

Medifirst Solutions to Present at the American Pain Association Conferences Focusing on Medical CBD and the Opioid Epidemic

Freehold, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on December 11, 2018 - 13:30 GMT

MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and ...

MYK-491 Demonstrated Increase in Contractility Consistent with Data from Preclinical and Healthy Volunteer Studies Multiple-Ascending Dose Phase 2a Clinical Trial in DCM and Systolic Heart Failure Patients Underway SOUTH SAN FRANCISCO, Calif., Dec. 11, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:30 GMT

Sarepta Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors

CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it appointed Mary Ann Gray, Ph.D., to its Board of Directors. Dr. Gray has more …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:27 GMT

Aptinyx to Present Preclinical Data on NMDA Receptor Modulator NYX-2925 at the American College of Neuropsychopharmacology’s ...

EVANSTON, Ill., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced two upcoming poster …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:05 GMT

Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian ...

HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the company has begun treating patients in the Phase 1b portion of a Phase 1b/Phase 2 trial combining AVB-S6-500 with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (devimistat) in Combination with ...

Newark, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael), a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase 3 multicenter, open-label, randomized pivotal trial ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Operation Hat Trick Donates $10,000 to SoldierStrong

STAMFORD, Conn. and HAMPTON, N.H., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, has received a donation of $10,000 from Operation Hat Trick, which generates …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Comfort Launch by Vergence Naturals Exceeds Expectations

VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

HealthLynked to Attend the 2019 HIMSS Global Conference & Exhibition

NAPLES, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced that the Company will be attending the HIMSS Global Conference & Exhibition (Healthcare Information and Management Systems Society) taking place on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Marijuana Company of America Announces New hempSMART™ Website and Sales Platform

ESCONDIDO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce the launch of a new corporate hempSMART™ …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:45 GMT

T1D Exchange Names New Board Members

David Walton, MBA Mr. Walton is the Founder and CEO of Pennsylvania-based Chronicare, a digital health company utilizing connected monitoring solutions to improve medication adherence and outcomes in people with diabetes and other chronic diseases. He …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:35 GMT

Intensity Therapeutics Strengthens Intellectual Property Portfolio with Issuance of Several New Patents in Asia and Australia

WESTPORT, Conn., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition of solid tumor cancers, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on December 11, 2018 - 12:30 GMT

REMINDER: Moleculin Announces Conference Call to Discuss Recent Breakthrough Discovery and FDA Filing on Wednesday, December 12, ...

HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:30 GMT

Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial

- Phase 2 enrollment completed; interim clinical data show reductions in both inflammation and reported pain after first dose and throughout treatment period - Pivotal Phase 3 clinical trial, RHAPSODY, now actively recruiting and screening subjects …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:30 GMT

SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA

PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its second and third …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:05 GMT

Helius Medical Technologies, Inc. Announces Exercise of Underwriters’ Overallotment Option

NEWTOWN, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”) announced today that the underwriters of its previously announced public offering of 2,121,212 shares of Class A common …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL

YARDLEY, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company received written notice from Avanir …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer

BUFFALO, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that its global Phase 1b …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Previous 6 7 8 9 10 11 12 13 14 15 16 Next

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

Browse by Topic